Share on StockTwits

Mead Johnson Nutrition CO (NYSE:MJN) SVP Dirk Hondmann sold 1,503 shares of the company’s stock on the open market in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $87.83, for a total transaction of $132,008.49. Following the transaction, the senior vice president now directly owns 14,559 shares of the company’s stock, valued at approximately $1,278,717. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Mead Johnson Nutrition CO (NYSE:MJN) traded down 1.36% on Thursday, hitting $85.7796. 726,455 shares of the company’s stock traded hands. Mead Johnson Nutrition CO has a 1-year low of $66.80 and a 1-year high of $88.87. The stock’s 50-day moving average is $85.54 and its 200-day moving average is $82.82. The company has a market cap of $17.336 billion and a price-to-earnings ratio of 26.60.

Mead Johnson Nutrition CO (NYSE:MJN) last released its earnings data on Thursday, April 24th. The company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.11. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the previous year, the company posted $0.85 earnings per share. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition CO will post $3.70 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Societe Generale raised their price target on shares of Mead Johnson Nutrition CO from $94.00 to $100.00 in a research note on Monday, April 28th. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Mead Johnson Nutrition CO in a research note on Tuesday, April 22nd. They now have a $92.00 price target on the stock, down previously from $93.00. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Mead Johnson Nutrition CO from $89.00 to $92.00 in a research note on Monday, March 10th. They now have an “overweight” rating on the stock. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Mead Johnson Nutrition CO presently has a consensus rating of “Buy” and a consensus price target of $94.26.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.